Speaker illustration

Doctor Claudio Espada Guerreiro

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)

Member of:

EAPCI

Impact of myocardial fibrosis in left ventricular remodeling after aortic valve replacement (AVR) for severe aortic stenosis (AS)

Event: ESC Congress 2018

Topic: Valvular Heart Disease

Session: Assessment of valve disease

Thumbnail

Magnetic resonance predictors of ventricular arrhythmia in patients with prior myocarditis

Event: ESC Congress 2018

Topic: Myocarditis

Session: Myocarditis

Thumbnail

Percutaneous treatment of severe mitral regurgitation with mitraclip device: potential role of NT-proBNP in prognosis assessment

Event: ESC Congress 2018

Topic: Biomarkers

Session: Chronic heart failure – Diagnostic methods

Thumbnail

Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome

Event: ESC CONGRESS 2017

Topic: Acute intensive cardiovascular care

Session: Latest on STEMI

Thumbnail

Aortic valve hemodynamic deterioration after transcatheter aortic valve implantation (TAVI) and its association with anti-thrombotic therapy.

Event: ESC CONGRESS 2017

Topic: Aortic valve surgery

Session: Trans-catheter valve interventions and their complications

Thumbnail

Modification of mitral regurgitation after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis

Event: ESC CONGRESS 2016

Topic: Non coronary cardiac interventions

Session: Non-coronary cardiac interventions and more

Thumbnail

This platform is supported by

logo Novo Nordisk